Moreover, in our work, immune deconvolution using an independent transcriptome dataset demonstrated a distinct immune profile between NOS NSCLC and sarcomas regardless of the SMARCA4 mutational status. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.